Fernandez-Aviles, ConsueloCastillo, Juan CHeredia, GloriaResua, AdrianaGonzalez, RafaelPan, ManuelAnguita, Manuel2023-05-032023-05-032021-10-28Fernández-Avilés C, Castillo JC, Heredia G, Resúa A, González R, Pan M, et al. Infective endocarditis on transcatheter aortic prosthesis: Are there differences with endocarditis on surgically implanted aortic bioprosthesis? Cardiol J. 2022;29(3):511-513http://hdl.handle.net/10668/21659Transcatheter aortic valve implantation (TAVI) has been a major advance in the treatment of aortic stenosis in elderly patients or those at very high surgical risk, and its indication has been extended to cases of high or even intermediate risk. For this reason, its use has increased notably in the past years [1]. One of the problems associated with TAVI is bioprosthesis infection [2]. The development of infective endocarditis (IE) on TAVI (IETAVI) is a serious complication, with the added problem that in many cases open-heart surgery is necessary to manage it.enAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/EndocarditisEndocarditis, bacterialHeart valve prosthesisHeart valve prosthesis implantationAortic valveBioprosthesisHumansProsthesis designProsthesis failureresearch article34787886open accessBioprótesisDiseño de prótesisFalla de prótesisVálvula aórtica10.5603/CJ.a2021.01531898-018XPMC9170327https://journals.viamedica.pl/cardiology_journal/article/download/CJ.a2021.0153/64801https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170327/pdf